Loading data for SAN.PA — first visit, this takes a few seconds.
Sanofi (SAN.PA)
Paris: SAN.PA
· Real-Time Price · USD
78.78
+0.04 (0.05%)
At close: Sep 02, 2026, 3:36 PM
The price, the headline numbers and the latest news, in one place.
Sanofi (SAN.PA) Stock Price, Analysis & Data
No data available
| Bid | 0 |
| Market Cap | 92.4B |
| Revenue (ttm) | 48.9B |
| Net Income (ttm) | 3.94B |
| 0.28 | |
| 3.24 | |
| 23.81 | |
| 8.52 | |
| P/B (ttm) | 1.34 |
| P/S (ttm) | 1.89 |
| Earnings Date | Oct 30, 2026 |
| Ask | 0 |
| Volume | 335,925 |
| Avg. Volume (20D) | 2,336,227 |
| Open | 79.16 |
| Previous Close | 78.74 |
| Day's Range | 78.61 - 79.36 |
| 52-Week Range | 71.25 - 91.15 |
| Analyst | n/a |
| Price Target | n/a |
| Dividends | $4.12 (5.36%) |
| Ex-Dividend Date | May 5, 2026 |
About SAN.PA
Sanofi engages in the research, development, manufacture, and marketing of therapeutic solutions. It provides immunology and inflammation, rare diseases neurology, oncology, and other vaccines. It also offers poliomyelitis, pertussis, and haemophilus influenzae type b (Hib) pediatric vaccines; respiratory syncytial virus protection and hexavalent combination vaccines that includes hepatitis A, typhoid, yellow fever, and rabies vaccines. It has a ...
Industry Drug Manufacturers - General
Sector Healthcare
IPO Date Jan 3, 2000
Employees 74,846
Stock Exchange Paris
Ticker Symbol SAN.PA
Website https://www.sanofi.com
Financial Performance
In 2025, Sanofi's revenue was 46.72B, an increase of 5.49% compared to the previous year's 44.29B. Earnings were 7.81B, an increase of 40.52%.
Financial numbers in EUR Financial StatementsEarnings Surprise
Sanofi has released their quarterly earnings on Jul 30, 2026:
- Revenue of $12.3B misses estimates by $0, with 14.58% YoY growth.
- EPS of 2.09 exceeds estimates by 0.19, with 31.45% YoY growth.
Sanofi is scheduled to release its earnings on Oct 30, 2026, during market hours.
Analysts project revenue of ... Upgrade
Analysts project revenue of ... Upgrade
Page 1 of 2